Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic”

813 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 813 results

Post-approval studies (Phase 4)Study completedNCT00137020
What this trial is testing

Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 294
Not applicableStudy completedNCT01160679
What this trial is testing

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 231
Post-approval studies (Phase 4)Study completedNCT00191555
What this trial is testing

Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment

Who this might be right for
Schizophrenia
Eli Lilly and Company 360
Post-approval studies (Phase 4)WithdrawnNCT01567124
What this trial is testing

Alleviating the Metabolic Side Effects of Antipsychotic Medications

Who this might be right for
Schizophrenia
Baker Heart and Diabetes Institute
Not applicableStudy completedNCT01931059
What this trial is testing

Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

Who this might be right for
Imaging of the Brain and AntipsychoticsNeuronal Network Changes
Northwell Health 11
Not applicableStudy completedNCT02600741
What this trial is testing

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 296
Post-approval studies (Phase 4)Ended earlyNCT01844700
What this trial is testing

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

Who this might be right for
High Risk MC4R GenotypeLow Risk MC4R GenotypeOne Week or Less Antipsychotic Lifetime Exposure
Northwell Health 14
Not applicableStudy completedNCT03110471
What this trial is testing

Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation

Who this might be right for
Dementia
Swansea University 60
Large-scale testing (Phase 3)Study completedNCT02013609
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

Who this might be right for
MDD
Otsuka Pharmaceutical Development & Commercialization, Inc. 48
Post-approval studies (Phase 4)Study completedNCT00854919
What this trial is testing

Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder

Who this might be right for
SSRI-Refractory Obsessive-Compulsive Disorder
Osaka City University
Post-approval studies (Phase 4)Not Yet RecruitingNCT06546475
What this trial is testing

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

Who this might be right for
Psychosis
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00314639
What this trial is testing

Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

Who this might be right for
Schizophrenia and Schizophrenia Spectrum Psychosis
Laval University 30
Post-approval studies (Phase 4)UnknownNCT00837707
What this trial is testing

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Drug-Induced
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 25
Not applicableUnknownNCT03481465
What this trial is testing

Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis

Who this might be right for
SchizophreniaPsychosisMetabolic Syndrome
Fundación Marques de Valdecilla 200
Large-scale testing (Phase 3)Study completedNCT02013531
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Who this might be right for
Major Depressive DisorderAnxiety
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Large-scale testing (Phase 3)Study completedNCT05838625
What this trial is testing

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Click Therapeutics, Inc. 464
Large-scale testing (Phase 3)Study completedNCT02983188
What this trial is testing

Berberine as Adjuvant Treatment for Schizophrenia Patients

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersMetabolic Syndrome x
The University of Hong Kong 113
Post-approval studies (Phase 4)WithdrawnNCT00786318
What this trial is testing

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

Who this might be right for
PsychosisAgitationDelirium
George Washington University
Not applicableStudy completedNCT00169988
What this trial is testing

Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

Who this might be right for
Prodromal SchizophreniaPsychotic Disorders
Northwell Health 8
Not applicableUnknownNCT03062033
What this trial is testing

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 70
Next Page